Health Canada Authorizes Pfizer-Biontech Omicron Ba.4/Ba.5 Bivalent-Adapted Covid-19 Booster For Children 5 To 11 Years Of Age

Published on December 09, 2022 12:26 PM EST

Dec 9 (Reuters) - Health Canada :

* HEALTH CANADA AUTHORIZES PFIZER-BIONTECH OMICRON BA.4/BA.5 BIVALENT-ADAPTED COVID-19 BOOSTER FOR CHILDREN 5 TO 11 YEARS OF AGE

* HEALTH CANADA - REQUIRES PFIZER-BIONTECH TO PROVIDE INFORMATION ON SAFETY AND EFFICACY OF COMIRNATY OMICRON BA.4/BA.5 BIVALENT-ADAPTED BOOSTER VACCINE

* HEALTH CANADA - HAS PLACED TERMS, CONDITIONS ON AUTHORIZATION FOR PFIZER-BIONTECH COMIRNATY OMICRON BA.4/BA.5 BIVALENT-ADAPTED BOOSTER VACCINE Source text for Eikon: Further company coverage:

Reuters

Reuters -
96361 Posts
...

Disclaimer

The above content is directly sourced from Reuters under a contractual arrangement. The content is being provided as a convenience and for informational purposes only; and does not constitute an endorsement or approval by Kalkine Media of any of the products, services, or opinions of the organization or individual. The user is apprised that Kalkine Media bears no responsibility for the accuracy, legality, or content of Reuters, any external sites, or for that of subsequent links. The user is requested to contact Reuters directly for answers to questions regarding the content. Please note that Kalkine Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.